Savvy Advisors Inc’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.81M Buy
64,334
+11,165
+21% +$297K 0.05% 289
2025
Q4
$1.32M Buy
53,169
+23,015
+76% +$580K 0.04% 315
2025
Q3
$768K Buy
30,154
+2,223
+8% +$54.9K 0.04% 321
2025
Q2
$677K Buy
27,931
+2,906
+12% +$67.8K 0.05% 292
2025
Q1
$634K Sell
25,025
-1,399
-5% -$36.6K 0.06% 243
2024
Q4
$701K Buy
26,424
+2,085
+9% +$56.6K 0.08% 193
2024
Q3
$704K Buy
24,339
+3,058
+14% +$89.2K 0.14% 144
2024
Q2
$595K Buy
21,281
+1,838
+9% +$50.6K 0.19% 120
2024
Q1
$540K Buy
19,443
+93
+0.5% +$2.58K 0.31% 82
2023
Q4
$557K Buy
+19,350
New +$585K 0.54% 51

Other funds holding PFE

Savvy Advisors Inc's PFE Position: Q1 2026 in Review

Savvy Advisors Inc increased its Pfizer (PFE) stake by 21% in Q1 2026, buying an estimated $297K and bringing the position to 64,334 shares worth $1.81M. The position accounts for 0.05% of the portfolio, ranked #289.

Savvy Advisors Inc first reported a position in PFE in Q4 2023 and has held it in 10 quarters since. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Savvy Advisors Inc held 64,334 shares of Pfizer worth $1.81M as of Q1 2026.
  • Savvy Advisors Inc bought 11,165 Pfizer shares in Q1 2026, an estimated $297K.
  • Pfizer made up 0.05% of Savvy Advisors Inc's portfolio in Q1 2026, its #289 holding.
  • Savvy Advisors Inc first reported a position in Pfizer in Q4 2023 and has held it in 10 quarters since.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Savvy Advisors Inc's 13F filing for Q1 2026, filed 11 May 2026.